| 6B3S: reference: Molecular basis for necitumumab inhibition of EGFR variants associated with acquired cetuximab resistance., Bagchi A, Haidar JN, Eastman SW, Vieth M, Topper M, Iacolina MD, Walker JM, Forest A, Shen Y, Novosiadly RD, Ferguson KM, Mol Cancer Ther. 2017 Nov 20. pii: 1535-7163.MCT-17-0575. doi:, 10.1158/1535-7163.MCT-17-0575. PMID: 29158469 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).